IL-1 Trap: Phase III data

Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y.
Product: IL-1 Trap
Business: Inflammation
Molecular target: Interleukin-1 (IL-1)
Description: Recombinant protein with the heterodimeric interleukin-1 (IL-1) receptor linked

Read the full 258 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE